|
LRRC59 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28929999998473E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.797040E-04 |
| Normal-vs-Stage2 |
4.839900E-02 |
| Normal-vs-Stage3 |
4.004900E-03 |
| Normal-vs-Stage4 |
2.0216999999989E-05 |
| Stage1-vs-Stage2 |
5.971800E-01 |
| Stage1-vs-Stage3 |
3.169800E-01 |
| Stage1-vs-Stage4 |
1.611500E-02 |
| Stage2-vs-Stage3 |
2.318000E-01 |
| Stage2-vs-Stage4 |
1.759610E-02 |
| Stage3-vs-Stage4 |
3.271800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.73579999946428E-07 |
| Normal-vs-AfricanAmerican |
3.021600E-01 |
| Normal-vs-Asian |
2.122600E-01 |
| Caucasian-vs-AfricanAmerican |
4.055600E-02 |
| Caucasian-vs-Asian |
9.144800E-01 |
| AfricanAmerican-vs-Asian |
3.554400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.028000E-04 |
| Normal-vs-Female |
9.62519997038669E-09 |
| Male-vs-Female |
1.286240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.248980E-01 |
| Normal-vs-Age(41-60Yrs) |
2.229500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.59022999999259E-05 |
| Normal-vs-Age(81-100Yrs) |
1.047200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.067000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.764000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.022000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.987200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.198600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.111400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.137800E-01 |
| Normal-vs-Grade 2 |
3.237500E-04 |
| Normal-vs-Grade 3 |
1.004270E-03 |
| Normal-vs-Grade 4 |
4.64089999996364E-06 |
| Grade 1-vs-Grade 2 |
9.613400E-01 |
| Grade 1-vs-Grade 3 |
8.378800E-01 |
| Grade 1-vs-Grade 4 |
7.806400E-02 |
| Grade 2-vs-Grade 3 |
5.611000E-01 |
| Grade 2-vs-Grade 4 |
4.404800E-03 |
| Grade 3-vs-Grade 4 |
1.768140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.98209999999954E-05 |
| Normal-vs-ccB subtype |
1.838560E-04 |
| ccA subtype-vs-ccB subtype |
1.838980E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.60029999999912E-05 |
| Normal-vs-N1 |
1.021540E-02 |
| N0-vs-N1 |
5.804300E-02 |
|
|
